586 related articles for article (PubMed ID: 6591204)
21. Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles.
Bioletto S; Fontana P; Darioli R; James RW
Atherosclerosis; 1998 May; 138(1):207-15. PubMed ID: 9678786
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
Huang Y; Liu XQ; Rall SC; Mahley RW
J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
[TBL] [Abstract][Full Text] [Related]
24. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
[TBL] [Abstract][Full Text] [Related]
25. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia.
Fainaru M; Mahley RW; Hamilton RL; Innerarity TL
J Lipid Res; 1982 Jul; 23(5):702-14. PubMed ID: 7119569
[TBL] [Abstract][Full Text] [Related]
26. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
de Man FH; de Beer F; van de Laarse A; Smelt AH; Leuven JA; Havekes LM
Atherosclerosis; 1998 Feb; 136(2):255-62. PubMed ID: 9543096
[TBL] [Abstract][Full Text] [Related]
27. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
Murdoch SJ; Breckenridge WC
Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
[TBL] [Abstract][Full Text] [Related]
28. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Wang CS; Alaupovic P; Gregg RE; Brewer HB
Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
[TBL] [Abstract][Full Text] [Related]
29. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
[TBL] [Abstract][Full Text] [Related]
30. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.
Bersot TP; Innerarity TL; Pitas RE; Rall SC; Weisgraber KH; Mahley RW
J Clin Invest; 1986 Feb; 77(2):622-30. PubMed ID: 2935560
[TBL] [Abstract][Full Text] [Related]
31. Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
Dallongeville J; Boulet L; Davignon J; Lussier-Cacan S
Arterioscler Thromb; 1991; 11(4):864-71. PubMed ID: 2065040
[TBL] [Abstract][Full Text] [Related]
32. Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
Schmitz G; Assmann G; Augustin J; Dirkes-Kersting A; Brennhaüsen B; Karoff C
J Lipid Res; 1985 Mar; 26(3):316-26. PubMed ID: 3989390
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
Mendivil CO; Zheng C; Furtado J; Lel J; Sacks FM
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):239-45. PubMed ID: 19910636
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
[TBL] [Abstract][Full Text] [Related]
35. Resistance of a very low density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion to the low density lipoprotein density fraction.
Chung BH; Segrest JP
J Lipid Res; 1983 Sep; 24(9):1148-59. PubMed ID: 6631244
[TBL] [Abstract][Full Text] [Related]
36. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
Tam SP; Dory L; Rubinstein D
J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
[TBL] [Abstract][Full Text] [Related]
37. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.
Carlson LA; Holmquist L; Nilsson-Ehle P
Acta Med Scand; 1986; 219(5):435-47. PubMed ID: 3739751
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
[TBL] [Abstract][Full Text] [Related]
39. Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B.
Vega GL; East C; Grundy SM
Atherosclerosis; 1988 Mar; 70(1-2):131-43. PubMed ID: 3162680
[TBL] [Abstract][Full Text] [Related]
40. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
